Search research articles
Contact Us
Filters
Showing results (491-500 of 627) with videos related to
Page
of 63
Sort By:
JACC. Cardiovascular Interventions
|
August 20, 2016
Use of Dual Antiplatelet Therapy and Patient Outcomes in Those Undergoing Percutaneous Coronary Intervention: The ROCKET AF Trial
Matthew W Sherwood, Derek D Cyr, W Schuyler Jones, et al.
The American Journal of Cardiology
|
January 22, 2014
Association of aspirin dose and vorapaxar safety and efficacy in patients with non-ST-segment elevation acute coronary syndrome (from the TRACER Trial)
Kenneth W Mahaffey, Zhen Huang, Lars Wallentin, et al.
Journal of Cardiovascular Computed Tomography
|
July 25, 2022
Association of left ventricular diastolic function with coronary artery calcium score: A Project Baseline Health Study
Francois Haddad, Nicholas Cauwenberghs, Melissa A Daubert, et al.
American Heart Journal
|
February 11, 2021
Rivaroxaban versus warfarin in patients with atrial fibrillation enrolled in Latin America: Insights from ROCKET AF
Vanessa Blumer, Manuel Rivera, Ramón Corbalán, et al.
The New England Journal of Medicine
|
August 12, 2011
Rivaroxaban versus warfarin in nonvalvular atrial fibrillation
Manesh R Patel, Kenneth W Mahaffey, Jyotsna Garg, et al.
Journal of the American College of Cardiology
|
November 5, 2013
Impact of intraprocedural stent thrombosis during percutaneous coronary intervention: insights from the CHAMPION PHOENIX Trial (Clinical Trial Comparing Cangrelor to Clopidogrel Standard of Care Therapy in Subjects Who Require Percutaneous Coronary Intervention)
Philippe Généreux, Gregg W Stone, Robert A Harrington, et al.
Clinical Cardiology
|
June 30, 2019
The efficacy and safety of cangrelor in single vessel vs multivessel percutaneous coronary intervention: Insights from CHAMPION PHOENIX
Celina M Yong, Vandana Sundaram, Freddy Abnousi, et al.
Journal of the American Heart Association
|
April 27, 2019
Comparison of Patient-Reported Care Satisfaction, Quality of Warfarin Therapy, and Outcomes of Atrial Fibrillation: Findings From the ORBIT - AF Registry
Alexander C Perino, Peter Shrader, Mintu P Turakhia, et al.
American Heart Journal
|
April 30, 2017
Differential occurrence, profile, and impact of first recurrent cardiovascular events after an acute coronary syndrome
Connie N Hess, Robert M Clare, Megan L Neely, et al.
Journal of the American College of Cardiology
|
February 9, 2013
Outcomes of discontinuing rivaroxaban compared with warfarin in patients with nonvalvular atrial fibrillation: analysis from the ROCKET AF trial (Rivaroxaban Once-Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation)
Manesh R Patel, Anne S Hellkamp, Yuliya Lokhnygina, et al.
Page
of 63
Search research articles
Search
Showing results (491-500 of 627) with videos related to
Sort By:
Page
of 63
JACC. Cardiovascular Interventions
|
August 20, 2016
Use of Dual Antiplatelet Therapy and Patient Outcomes in Those Undergoing Percutaneous Coronary Intervention: The ROCKET AF Trial
Matthew W Sherwood, Derek D Cyr, W Schuyler Jones, et al.
The American Journal of Cardiology
|
January 22, 2014
Association of aspirin dose and vorapaxar safety and efficacy in patients with non-ST-segment elevation acute coronary syndrome (from the TRACER Trial)
Kenneth W Mahaffey, Zhen Huang, Lars Wallentin, et al.
Journal of Cardiovascular Computed Tomography
|
July 25, 2022
Association of left ventricular diastolic function with coronary artery calcium score: A Project Baseline Health Study
Francois Haddad, Nicholas Cauwenberghs, Melissa A Daubert, et al.
American Heart Journal
|
February 11, 2021
Rivaroxaban versus warfarin in patients with atrial fibrillation enrolled in Latin America: Insights from ROCKET AF
Vanessa Blumer, Manuel Rivera, Ramón Corbalán, et al.
The New England Journal of Medicine
|
August 12, 2011
Rivaroxaban versus warfarin in nonvalvular atrial fibrillation
Manesh R Patel, Kenneth W Mahaffey, Jyotsna Garg, et al.
Journal of the American College of Cardiology
|
November 5, 2013
Impact of intraprocedural stent thrombosis during percutaneous coronary intervention: insights from the CHAMPION PHOENIX Trial (Clinical Trial Comparing Cangrelor to Clopidogrel Standard of Care Therapy in Subjects Who Require Percutaneous Coronary Intervention)
Philippe Généreux, Gregg W Stone, Robert A Harrington, et al.
Clinical Cardiology
|
June 30, 2019
The efficacy and safety of cangrelor in single vessel vs multivessel percutaneous coronary intervention: Insights from CHAMPION PHOENIX
Celina M Yong, Vandana Sundaram, Freddy Abnousi, et al.
Journal of the American Heart Association
|
April 27, 2019
Comparison of Patient-Reported Care Satisfaction, Quality of Warfarin Therapy, and Outcomes of Atrial Fibrillation: Findings From the ORBIT - AF Registry
Alexander C Perino, Peter Shrader, Mintu P Turakhia, et al.
American Heart Journal
|
April 30, 2017
Differential occurrence, profile, and impact of first recurrent cardiovascular events after an acute coronary syndrome
Connie N Hess, Robert M Clare, Megan L Neely, et al.
Journal of the American College of Cardiology
|
February 9, 2013
Outcomes of discontinuing rivaroxaban compared with warfarin in patients with nonvalvular atrial fibrillation: analysis from the ROCKET AF trial (Rivaroxaban Once-Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation)
Manesh R Patel, Anne S Hellkamp, Yuliya Lokhnygina, et al.
Page
of 63